VINCOV-19
GS PAPER III: Science and Technology- developments and their applications and effects in everyday life.
Context: The CSIR- Centre for Cellular and Molecular Biology has developed, possibly the first specific drug for COVID-19 treatment, which contain therapeutic antibodies.
More about news:
- The Drug Controller General of India (DGCI) has given its approval for human trials, Phase-I and Phase-II for the VINCOV-19 and expected to be tried next week in Delhi and Rajasthan.
- Developed by the CCMB, University of Hyderabad and Vins Bioproduct ltd combine, the VINCOV-19 is a collection of antibodies from Horses after they got injected inactivated Corona virus.
- It may take 3-4 weeks for getting approval for emergency use.
- VINCOV may be the first specific drug for COVID treatment and it works best when given on early stage of infection.